Sercan Biyun Wang et al. [20] found that miR-122 took the crucial role of a tumour suppressor by targeting IGF1R and regulating the PI3K/Akt/mTOR/p70S6K pathway in breast cancer. Here, RPS6KB1 is linked to neoplasm.